Harnessing Data Analytics to Improve the Lives of Individuals and Families: A National Data Strategy
Summary
Fragmented federal program structures and laws create enormous barriers to effective coordination across government agencies and levels of government. The next administration can advance the nation’s health and economic well-being and improve the effectiveness of taxpayer investments by creating the enabling conditions for federal, state, and local decision-makers and managers to adopt modern data analytics tools and practices.
Note: As a working paper, this draft is still under development. The author invites your feedback and comments, which can be sent to info@dayoneproject.org.
Given the rapid pace of AI advancement, a proactive effort triumphs over a reactive one. To protect consumers, workers, and the economy more broadly, it is imperative that the FTC and DOJ adapt their enforcement strategies to meet the complexities of the AI era.
To encourage greater adoption of generic drugs in clinical practice the FDA should implement a dedicated regulatory pathway for non-manufacturers to seek approval of new indications for repurposed generic drugs.
By leveraging its substantial purchasing power responsibly, the government can encourage high-quality, inclusive AI solutions that address diverse citizen needs while setting a strong precedent for innovation and accountability.
The federal government should expand the FDA’s priority review voucher program and provide market exclusivity advantages to encourage the development of medications for addiction.